Double Bond Pharmaceutical International AB (DBPHAb)

Currency in SEK
0.1730
+0.0110(+6.79%)
Closed·
DBPHAb Scorecard
Full Analysis
Stock has taken a big hit over the last week
DBPHAb is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
0.15600.1730
52 wk Range
0.10000.6300
Key Statistics
Bid/Ask
0.156 / 0.1715
Prev. Close
0.162
Open
0.156
Day's Range
0.156-0.173
52 wk Range
0.1-0.63
Volume
10.09K
Average Volume (3m)
459.65K
1-Year Change
-58.81%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
DBPHAb Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Stock generally trades with high price volatility

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy

Double Bond Pharmaceutical International AB Company Profile

Double Bond Pharmaceutical International AB (publ), a pharmaceutical company, engages in the development and commercialization of approaches for the treatment of oncological and infectious diseases. It offers Temodex/SI-053, a therapy to treat malignant brain tumors; and SA033, a therapy to treat cancers in liver. The company is also developing Belopenem for the treatment of bacterial pneumonia. Double Bond Pharmaceutical International AB (publ) was incorporated in 2014 and is based in Uppsala, Sweden.

Employees
9
Market
Sweden

Compare DBPHAb to Peers and Sector

Metrics to compare
DBPHAb
Peers
Sector
Relationship
P/E Ratio
−6.2x0.0x−0.5x
PEG Ratio
−0.090.000.00
Price/Book
12.3x0.0x2.6x
Price / LTM Sales
4.9x0.0x3.3x
Upside (Analyst Target)
-0.0%43.5%
Fair Value Upside
Unlock0.0%6.8%Unlock

Earnings

Latest Release
May 22, 2025
EPS / Forecast
-0.01 / --
Revenue / Forecast
1.44M / --
EPS Revisions
Last 90 days

DBPHAb Income Statement

FAQ

What Stock Exchange Does Double Bond Pharma Trade On?

Double Bond Pharma is listed and trades on the Spotlight Stock Market stock exchange.

What Is the Stock Symbol for Double Bond Pharma?

The stock symbol for Double Bond Pharma is "DBPHAb."

What Is the Double Bond Pharma Market Cap?

As of today, Double Bond Pharma market cap is 35.60M.

What Is Double Bond Pharma's Earnings Per Share (TTM)?

The Double Bond Pharma EPS (TTM) is -0.05.

From a Technical Analysis Perspective, Is DBPHAb a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Sell.

How Many Times Has Double Bond Pharma Stock Split?

Double Bond Pharma has split 2 times.

How Many Employees Does Double Bond Pharma Have?

Double Bond Pharma has 9 employees.

What is the current trading status of Double Bond Pharma (DBPHAb)?

As of 09 Aug 2025, Double Bond Pharma (DBPHAb) is trading at a price of 0.17, with a previous close of 0.16. The stock has fluctuated within a day range of 0.16 to 0.17, while its 52-week range spans from 0.10 to 0.63.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.